-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22731f26-a4a8-4bf1-9235-cfbefe35116b&Preview=1 -
Date
5/26/2011 -
Company Name
Vestaron -
Mailing Address
4717 Campus Drive Kalamazoo, MI 49008 -
Company Description
Vestaron Corporation is developing a new generation of insecticides by employing peptides sourced from spiders – insecticides that are ideally suited for the environmentally conscious, twenty-first century. Over 50 unique, spider-venom peptides with novel sites of action have been identified and are being exploited. This patented technology is exclusively licensed to Vestaron. The company has three initial spider venom-based active ingredients under development. All three are highly effective against insects and related pests and all are harmless to non-target species, including humans. Because Vestaron insecticides work through active sites that are different and distinct from current chemical pesticides, they bypass the existing problems of insect resistance and cross reactivity. -
Website
http://www.vestaron.com -
Transaction Type
Venture Equity -
Transaction Amount
$444,999 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed













